Prof. Rui Reis interview on “Consultório” at “Porto Canal” about Portuguese new regulations on embryonic stem cells research. [March 11, 2011] Video Rating: 5 / 5
A trailer based off of my research paper for the Expository Literature final. By Esther and Kelly Cited in order of appearance: www.youtube.com www.youtube.com www.youtube.com www.youtube.com Video Rating: 0 / 5
Hadassah hospital in Israel is one of the leading hospitals in the world. Hadassah’s Bone Marrow Transplantation Center (BMT) and Cancer Immunotherapy and Cell Therapy Research Center is lead by Prof. Reuven Or. The center offers various types of treatments including autologous and allogeneic stem cells transplantation using various types of donors, with bone marrow, blood, and cord blood used as sources of stem cells. The treatments are performed in the serenity environment of Jerusalem and are offered at moderate prices. Request for information at: www.hadassah.org.il Video Rating: 0 / 5
Read the Transcript: to.pbs.org A federal judge issued a ruling to stop government-funded human embryonic stem cell research. Judge Royce Lamberth ordered the ban to ‘preserve the status quo’ that existed before President Obama expanded the guidelines last March. Judy Woodruff gets two views on the ruling. Video Rating: 5 / 5
Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Several broad categories of stem cells exist, including: embryonic stem cells (derived from blastocysts), fetal stem cells (obtained from aborted fetuses), adult stem cells (found in adult tissues), cord blood stem cells (isolated from umbilical tissue), cancer stem cells (which give rise to a clonal populations of cells that form tumors or disperse in the body), and animal stem cells (derived from non-human sources).
In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells. Of interest to researchers, is the potential for use stem cells in regenerative medicine to treat conditions ranging from diabetes, to cardiovascular disease and neurological disorders. Additionally, the ability to use stem cells to improve drug target validation and toxicology screening is of intense interest to pharmaceutical companies. Stem cells are also being studied for their ability to improve both the understanding and treatment of birth disorders.
To facilitate the research resulting from interest in these far-ranging applications, a sizeable stem cells research products market has emerged. Large companies selling stem cell research products include Invitrogen, BD Biosciences, Thermo Fisher Scientific, and Millipore, although many other suppliers exist as well. Products offered by these companies include: antibodies to stem cell antigens, bead-based stem cell separation systems, stem cell protein purification and analysis tools, tools for DNA and RNA-based characterization of stem cells, stem cell culture and media reagents, stem cell specific growth factors and cytokines, tools for stem cell gene regulation, a range of stem cell services, tools for in vivo and in vitro stem cell tracking, and stem cell lines.
Currently, the federal government is an important, although not dominant, source of funding for stem cell research. The reason is that states are spending almost as much as the federal government on general stem cell research and are actually spending more than the federal government on human embryonic stem cell (hESC) research. Private sources also contribute a huge about of funding, with analysis of recent large gifts summing to over .7 billion.
Specifically, market analysis determined the size of the stem cell research products market to be 2M and expanding through double digit growth each year. Because of the massive size of the market, developing a stem cells product line represents a significant financial opportunity for research supply companies. The purpose of this market analysis report is to explore current market conditions and provide guidance to companies that wish to offer a strategically positioned stem cell product line.
Bharatbook, the leading information aggregator. We facilitate and support the business information needs. With over 90,000 reports, you can get instant access and insights on the studies in you for market research, corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more your areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com
Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Several broad categories of stem cells exist, including: embryonic stem cells (derived from blastocysts), fetal stem cells (obtained from aborted fetuses), adult stem cells (found in adult tissues), cord blood stem cells (isolated from umbilical tissue), cancer stem cells (which give rise to a clonal populations of cells that form tumors or disperse in the body), and animal stem cells (derived from non-human sources).
In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells. Of interest to researchers, is the potential for use stem cells in regenerative medicine to treat conditions ranging from diabetes, to cardiovascular disease and neurological disorders. Additionally, the ability to use stem cells to improve drug target validation and toxicology screening is of intense interest to pharmaceutical companies. Stem cells are also being studied for their ability to improve both the understanding and treatment of birth disorders.
To facilitate the research resulting from interest in these far-ranging applications, a sizeable stem cells research products market has emerged. Large companies selling stem cell research products include Invitrogen, BD Biosciences, Thermo Fisher Scientific, and Millipore, although many other suppliers exist as well. Products offered by these companies include: antibodies to stem cell antigens, bead-based stem cell separation systems, stem cell protein purification and analysis tools, tools for DNA and RNA-based characterization of stem cells, stem cell culture and media reagents, stem cell specific growth factors and cytokines, tools for stem cell gene regulation, a range of stem cell services, tools for in vivo and in vitro stem cell tracking, and stem cell lines.
Currently, the federal government is an important, although not dominant, source of funding for stem cell research. The reason is that states are spending almost as much as the federal government on general stem cell research and are actually spending more than the federal government on human embryonic stem cell (hESC) research. Private sources also contribute a huge about of funding, with analysis of recent large gifts summing to over .7 billion.
Specifically, market analysis determined the size of the stem cell research products market to be 2M and expanding through double digit growth each year. Because of the massive size of the market, developing a stem cells product line represents a significant financial opportunity for research supply companies. The purpose of this market analysis report is to explore current market conditions and provide guidance to companies that wish to offer a strategically positioned stem cell product line.
Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies.
NSF awards stem cell bio-manufacturing research and education program to Georgia Tech
( Georgia Institute of Technology Research News ) The National Science Foundation has awarded million to Georgia Tech to fund a unique research program on stem cell bio-manufacturing. The program is specifically focused on developing engineering methods for stem cell production, in order to meet the anticipated demand for stem cells. Read more on EurekAlert!
NSF Awards Stem Cell Bio-Manufacturing Research & Education Program to Georgia Tech
The National Science Foundation has awarded million to Georgia Tech to fund a unique research program on stem cell bio-manufacturing. The program is specifically focused on developing engineering methods for stem cell production, in order to meet the anticipated demand for stem cells. Read more on Newswise
(out of reviews)
